Bio-Rad Laboratories Inc (BIO)
290.25
-1.59
(-0.54%)
USD |
NYSE |
May 23, 16:00
290.31
+0.06
(+0.02%)
Pre-Market: 20:00
Bio-Rad Laboratories Revenue (Annual): 2.671B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.671B |
| December 31, 2022 | 2.802B |
| December 31, 2021 | 2.923B |
| December 31, 2020 | 2.546B |
| December 31, 2019 | 2.312B |
| December 31, 2018 | 2.289B |
| December 31, 2017 | 2.160B |
| December 31, 2016 | 2.068B |
| December 31, 2015 | 2.019B |
| December 31, 2014 | 2.175B |
| December 31, 2013 | 2.133B |
| December 31, 2012 | 2.069B |
| December 31, 2011 | 2.074B |
| December 31, 2010 | 1.927B |
| December 31, 2009 | 1.784B |
| December 31, 2008 | 1.764B |
| December 31, 2007 | 1.461B |
| December 31, 2006 | 1.274B |
| December 31, 2005 | 1.181B |
| December 31, 2004 | 1.090B |
| Date | Value |
|---|---|
| December 31, 2003 | 979.63M |
| December 31, 2002 | 865.01M |
| December 31, 2001 | 817.51M |
| December 31, 2000 | 725.88M |
| December 31, 1999 | 555.40M |
| December 31, 1998 | 447.86M |
| December 31, 1997 | 426.90M |
| December 31, 1996 | 418.80M |
| December 31, 1995 | 396.60M |
| December 31, 1994 | 355.30M |
| December 31, 1993 | 328.60M |
| December 31, 1992 | 330.30M |
| December 31, 1991 | 310.70M |
| December 31, 1990 | 286.70M |
| December 31, 1989 | 236.30M |
| December 31, 1988 | 198.90M |
| December 31, 1987 | 159.50M |
| December 31, 1986 | 126.60M |
| December 31, 1985 | 102.30M |
| December 31, 1984 | 84.60M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.312B
Minimum
2019
2.923B
Maximum
2021
2.651B
Average
2.671B
Median
2023
Revenue (Annual) Benchmarks
| Agilent Technologies Inc | 6.833B |
| Azenta Inc | 665.07M |
| Harvard Bioscience Inc | 112.25M |
| Bionano Genomics Inc | 36.12M |
| Akoya Biosciences Inc | 96.63M |